[1]
Husain, N., Agrawal, P.K., Ahmad, A. and Seth, R.N. 2026. Alfuzosin versus tamsulosin for symptomatic benign prostatic hyperplasia: a prospective comparative study. International Journal of Basic & Clinical Pharmacology. 15, 5 (Aug. 2026), 932–936. DOI:https://doi.org/10.18203/2319-2003.ijbcp20262863.